Trials / Conditions / Breast Inflammatory Carcinoma

Breast Inflammatory Carcinoma

9 registered clinical trials studyying Breast Inflammatory Carcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial NCT07474090	Wake Forest University Health Sciences	N/A
Withdrawn	SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Can NCT05093387	Northwestern University	Phase 1
Withdrawn	Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV T NCT05177796	M.D. Anderson Cancer Center	Phase 2
Terminated	Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer NCT05041101	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer NCT03598257	National Cancer Institute (NCI)	Phase 2
Recruiting	Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inf NCT03941756	M.D. Anderson Cancer Center	N/A
Terminated	Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treatin NCT03101748	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Tr NCT03012100	Academic and Community Cancer Research United	Phase 2
Active Not Recruiting	Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Ar NCT02971748	M.D. Anderson Cancer Center	Phase 2